M&A markets don't like volatility and unpredictability, and what we've seen in the past few weeks is the opposite of that,” ...
Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
US PRIVATE equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback